Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07473726 |
| Title | A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Shanghai Henlius Biotech |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Macquarie University | NOT_YET_RECRUITING | North Ryde | New South Wales | 2109 | Australia | Details |
| GenesisCare St.Leonards | NOT_YET_RECRUITING | Saint Leonards | New South Wales | 2065 | Australia | Details |
| Peninsula and South Eastern Haematology and Oncology Group | NOT_YET_RECRUITING | Frankston | Victoria | 3199 | Australia | Details |
| Zhujiang Hospital of Southern Medical University | NOT_YET_RECRUITING | Guangzhou | Guangdong | 510280 | China | Details |
| Sun Yat-Sen University Cancer Center | RECRUITING | Guangzhou | Guangzhou | 716099 | China | Details |
| Shanghai General Hospital | RECRUITING | Hongkou | Shanghai Municipality | 200080 | China | Details |
| Shanxi Provincial Cancer Hospital | NOT_YET_RECRUITING | Taiyuan | Shanxi | 030000 | China | Details |